Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Marchand

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Expert Opinion on Therapeutic Patents|August 17, 2011
Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitorsShar-yin N Huang, Yves Pommier, Christophe Marchand
Chemistry & Biology|June 11, 2010
DNA topoisomerases and their poisoning by anticancer and antibacterial drugsYves Pommier, Elisabetta Leo, HongLiang Zhang, et al.
Drug Discovery Today. Disease Mechanisms|September 30, 2011
Mechanisms and inhibition of HIV integrationChristophe Marchand, Allison A Johnson, Elena Semenova, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
Design and synthesis of photoactivatable aryl diketo acid-containing HIV-1 integrase inhibitors as potential affinity probesXuechun Zhang, Christophe Marchand, Yves Pommier, et al.
Proteomics|December 14, 2006
Comparative proteomic approaches for the isolation of proteins interacting with thioredoxinChristophe Marchand, Pierre Le Maréchal, Yves Meyer, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 14, 2008
Tyrosyl-DNA phosphodiesterase as a target for anticancer therapyThomas S Dexheimer, Smitha Antony, Christophe Marchand, et al.
Current Opinion in HIV and AIDS|April 18, 2009
Integration of human immunodeficiency virus as a target for antiretroviral therapyElena A Semenova, Allison A Johnson, Christophe Marchand, et al.
The Journal of Biological Chemistry|July 24, 2012
Biochemical characterization of human tyrosyl-DNA phosphodiesterase 2 (TDP2/TTRAP): a Mg(2+)/Mn(2+)-dependent phosphodiesterase specific for the repair of topoisomerase cleavage complexesRui Gao, Shar-yin N Huang, Christophe Marchand, et al.
The Journal of Biological Chemistry|January 5, 2002
Interaction of human nuclear topoisomerase I with guanosine quartet-forming and guanosine-rich single-stranded DNA and RNA oligonucleotidesChristophe Marchand, Philippe Pourquier, Gary S Laco, et al.
Journal of Medicinal Chemistry|May 8, 2014
Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitorsPeng-Cheng Lv, Keli Agama, Christophe Marchand, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Expert Opinion on Therapeutic Patents|August 17, 2011
Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitorsShar-yin N Huang, Yves Pommier, Christophe Marchand
Chemistry & Biology|June 11, 2010
DNA topoisomerases and their poisoning by anticancer and antibacterial drugsYves Pommier, Elisabetta Leo, HongLiang Zhang, et al.
Drug Discovery Today. Disease Mechanisms|September 30, 2011
Mechanisms and inhibition of HIV integrationChristophe Marchand, Allison A Johnson, Elena Semenova, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
Design and synthesis of photoactivatable aryl diketo acid-containing HIV-1 integrase inhibitors as potential affinity probesXuechun Zhang, Christophe Marchand, Yves Pommier, et al.
Proteomics|December 14, 2006
Comparative proteomic approaches for the isolation of proteins interacting with thioredoxinChristophe Marchand, Pierre Le Maréchal, Yves Meyer, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 14, 2008
Tyrosyl-DNA phosphodiesterase as a target for anticancer therapyThomas S Dexheimer, Smitha Antony, Christophe Marchand, et al.
Current Opinion in HIV and AIDS|April 18, 2009
Integration of human immunodeficiency virus as a target for antiretroviral therapyElena A Semenova, Allison A Johnson, Christophe Marchand, et al.
The Journal of Biological Chemistry|July 24, 2012
Biochemical characterization of human tyrosyl-DNA phosphodiesterase 2 (TDP2/TTRAP): a Mg(2+)/Mn(2+)-dependent phosphodiesterase specific for the repair of topoisomerase cleavage complexesRui Gao, Shar-yin N Huang, Christophe Marchand, et al.
The Journal of Biological Chemistry|January 5, 2002
Interaction of human nuclear topoisomerase I with guanosine quartet-forming and guanosine-rich single-stranded DNA and RNA oligonucleotidesChristophe Marchand, Philippe Pourquier, Gary S Laco, et al.
Journal of Medicinal Chemistry|May 8, 2014
Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitorsPeng-Cheng Lv, Keli Agama, Christophe Marchand, et al.
Pageof 11